Thrombin functions during tissue factor-induced blood coagulation

被引:305
作者
Brummel, KE [1 ]
Paradis, SG [1 ]
Butenas, S [1 ]
Mann, KG [1 ]
机构
[1] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA
关键词
D O I
10.1182/blood.V100.1.148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor-induced blood coagulation was studied in 20 individuals, for varying periods of time during 54 months, in contact pathway-inhibited whole blood at 37degreesC and evaluated in terms of the activation of various substrates. After quenching over time with inhibitors, the soluble phases were analyzed for thrombin-antithrombin III (TAT) complex formation, prothrombin fragments, platelet activation (osteonectin release), factor Va generation, fibrinopeptide (FP) A and FPB release, and factor XIII activation. TAT complex formation, for 35 experiments, showed an initiation phase (up to 4.6+/-0.6 minutes) in which thrombin was generated at an average rate of 0.93+/-0.3 nM/min catalyzed by about 1.3 pM prothrombinase yielding approximately 26 nM thrombin. During a subsequent propagation phase, thrombin was generated at a rate of 83.9+/-3.8 nM/min by about 120 pM prothrombinase, reaching ultimate levels of 851+/-53 nM. Clot time, determined subjectively, occurred at 4.7+/-0.2 minutes and correlated with the inception of the propagation phase. The thrombin concentrations associated with the transitions to rapid product formation are 510+/-180 pM for platelet activation (1.9+/-0.2 minutes), 840+/-280 pM for factor XIII activation and factor Va generation (2.2+/-0.6 minutes), 1.3+/-0.4 nM for FPA release (2.5+/-0.7 minutes), 1.7+/-0.5 nM for FPB release and prethrombin 2 (2.8+/-0.8 minutes), 7.0+/-2.2 nM for thrombin B chain (3.6+/-0.2 minutes), and 26+/-6.2 nM for the propagation phase of TAT formation (4.6+/-0.6 minutes). These results illustrate that the initial activation of thrombin substrates occurs during the initiation phase at less than 2 nM thrombin (0.2%). Most thrombin (96%) is formed well after clotting occurs.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 23 条
  • [1] PURIFICATION AND CHARACTERIZATION OF TAFI, A THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR
    BAJZAR, L
    MANUEL, R
    NESHEIM, ME
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14477 - 14484
  • [2] SIMPLE METHOD FOR PREPARATION OF HOMOGENEOUS PHOSPHOLIPID VESICLES
    BARENHOLZ, Y
    GIBBES, D
    LITMAN, BJ
    GOLL, J
    THOMPSON, TE
    CARLSON, FD
    [J]. BIOCHEMISTRY, 1977, 16 (12) : 2806 - 2810
  • [3] An integrated study of fibrinogen during blood coagulation
    Brummel, KE
    Butenas, S
    Mann, KG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) : 22862 - 22870
  • [4] Blood coagulation in hemophilia A and hemophilia C
    Cawthern, KM
    van't Veer, C
    Lock, JB
    DiLorenzo, ME
    Branda, RF
    Mann, KG
    [J]. BLOOD, 1998, 91 (12) : 4581 - 4592
  • [5] ACTIONS OF THROMBIN AND OTHER COAGULANT AND PROTEOLYTIC ENZYMES ON BLOOD PLATELETS
    DAVEY, MG
    LUSCHER, EF
    [J]. NATURE, 1967, 216 (5118) : 857 - &
  • [6] DOYLE MF, 1990, J BIOL CHEM, V265, P10693
  • [7] SUBUNIT STRUCTURE OF THROMBIN-ACTIVATED HUMAN FACTOR-VIIIA
    FAY, PJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 952 (02) : 181 - 190
  • [8] FOSTER WB, 1983, BLOOD, V61, P1060
  • [9] FACTOR-XI ACTIVATION IN A REVISED MODEL OF BLOOD-COAGULATION
    GAILANI, D
    BROZE, GJ
    [J]. SCIENCE, 1991, 253 (5022) : 909 - 912
  • [10] HIGGINS DL, 1983, J BIOL CHEM, V258, P9276